You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 3, March 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Juvenile Nasopharyngeal Angiofibroma Tumor Models

Failure of Androgens to Stimulate Growth in Nude Mice and In Vitro

Alan H. Shikani, MD; William J. Richtsmeier, MD, PhD

Arch Otolaryngol Head Neck Surg. 1992;118(3):256-259.


Abstract

• Juvenile nasopharyngeal angiofibroma is a tumor with a predilection for adolescent boys. It has been shown to contain cytosolic androgen receptors and to regress with estrogen therapy; however, the results have not been consistent. Extensive investigation has been unable to settle this issue in patients owing, in part, to the rarity of these tumors. We have attempted to establish a tumor model for juvenile nasopharyngeal angiofibroma by transplanting the tumor into the subdermal space of athymic mice and also by culturing it in vitro, to study the effect of hormonal manipulation. The tumor did survive in male and female athymic mice but has failed to grow. Androgen treatment of the mice of either sex did not alter its survival or growth behavior. The in vitro tissue culture grew fibroblastoid cells that were not stimulated by androgen supplementation. This study suggests that factors other than androgens are at least complementary, if not essential, in promoting the growth of juvenile nasopharyngeal angiofibroma in tumor models, and that androgens are not, in and of themselves, sufficient growth stimuli.

(Arch Otolaryngol Head Neck Surg. 1992;118:256-259)



Author Affiliations

From the Department of Otolaryngology—Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Md.


Footnotes

Accepted for publication June 27, 1991.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, The Johns Hopkins Medical Institutions, 600 N Wolfe St, Carnegie 400, Baltimore, MD 21205 (Dr Shikani).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vessel Density, Proliferation, and Immunolocalization of Vascular Endothelial Growth Factor in Juvenile Nasopharyngeal Angiofibromas
Brieger et al.
Arch Otolaryngol Head Neck Surg 2004;130:727-731.
ABSTRACT | FULL TEXT  

Angiofibroma: Changes in Staging and Treatment
Radkowski et al.
Arch Otolaryngol Head Neck Surg 1996;122:122-129.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.